Anticorps Polyclonal de lapin anti-NUF2

• Phare
• Validé par KD/KO

NUF2 Polyclonal Antibody for WB, IP, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain et plus (1)

Applications

WB, IHC, IP, ELISA

Conjugaison

Non conjugué

Publications(8)

Avis (1)

N° de cat : 15731-1-AP

Synonymes

CDCA1, hNuf2, hNuf2R, hsNuf2, Kinetochore protein Nuf2, NUF2, NUF2R

---

Galerie de données de validation

• 

  WB analysis using 15731-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 15731-1-AP (NUF2 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of HepG2 using 15731-1-AP

  WB result of NUF2 antibody (15731-1-AP; 1:2000; incubated at room temperature for 1.5 hours) with sh-Control and sh-NUF2 transfected HepG2 cells.

• 

  WB analysis of human testis using 15731-1-AP

  human testis tissue were subjected to SDS PAGE followed by western blot with 15731-1-AP (NUF2 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

• 

  WB analysis of PC-3 using 15731-1-AP

  PC-3 cells were subjected to SDS PAGE followed by western blot with 15731-1-AP (NUF2 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

• 

  WB analysis of HeLa using 15731-1-AP

  HeLa cells were subjected to SDS PAGE followed by western blot with 15731-1-AP (NUF2 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

• 

  WB analysis of human liver using 15731-1-AP

  human liver tissue were subjected to SDS PAGE followed by western blot with 15731-1-AP (NUF2 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

• 

  WB analysis of human skeletal muscle using 15731-1-AP

  human skeletal muscle tissue were subjected to SDS PAGE followed by western blot with 15731-1-AP (NUF2 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

• 

  IP experiment of HEK-293 using 15731-1-AP

  IP result of anti-NUF2 (IP:15731-1-AP, 3ug; Detection:15731-1-AP 1:500) with HEK-293 cells lysate 1760ug.

---

Applications testées

• Résultats positifs en WB: cellules HEK-293, cellules HeLa, cellules HepG2, cellules PC-3, tissu de muscle squelettique humain, tissu hépatique humain, tissu testiculaire humain
• Résultats positifs en IP: cellules HEK-293

Dilution recommandée

• Western Blot (WB): WB : 1:500-1:2000
• Immunoprécipitation (IP): IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Applications publiées

• KD/KO: See 2 publications below
• WB: See 7 publications below
• IHC: See 3 publications below
• IP: See 1 publications below

Informations sur le produit

15731-1-AP cible NUF2 dans les applications de WB, IHC, IP, ELISA et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Réactivité citée: Humain, souris
• Hôte / Isotype: Lapin / IgG
• Clonalité: Polyclonal
• Type: Anticorps
• Immunogène: NUF2 Protéine recombinante Ag8479
• Nom complet: NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae)
• Masse moléculaire calculée: 464 aa, 54 kDa
• Poids moléculaire observé: 50 kDa
• Numéro d’acquisition GenBank: BC008489
• Symbole du gène: NUF2
• Identification du gène (NCBI): 83540
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par affinité contre l'antigène
• Tampon de stockage: PBS with 0.02% sodium azide and 50% glycerol
• Conditions de stockage: Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20^oC Les 20ul contiennent 0,1% de BSA.

Informations générales

NUF2 (NUF2, Ndc80 kinetochore complex component) plays an important role in kinetochore-microtubule attachment. NUF2 was reported to be overexpressed in various kinds of carcinomas including lung cancer, cholangiocellular cancer, urinary bladder cancer, renal cell cancer, colorectal cancer, gastric cancer, ovarian cancer and serous adenocarcinoma. Elevated expression of NUF2 was associated with poorer prognosis of non-small cell lung cancer patients (PMID: 17079454). Knockdown of NUF2 significantly caused cell growth delay and increased apoptosis in cell lines of non-small cell lung cancer, colorectal cancer, gastric cancer and ovarian cancer.

Publications

Species	Application	Title
human	WB	Cell Death Dis; LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription.; Authors - Xina Xie
human	WB,IHC	Int J Biol Sci; NUF2 Drives Clear Cell Renal Cell Carcinoma by Activating HMGA2 Transcription through KDM2A-mediated H3K36me2 Demethylation; Authors - Jiatian Lin ; KD Validated
human,mouse	WB	Front Oncol; NUF2 overexpression contributes to epithelial ovarian cancer progression via ERBB3-mediated PI3K-AKT and MAPK signaling axes; Authors - Ruobing Leng ; KD Validated
human	WB	Adv Sci (Weinh); CCDC68 Maintains Mitotic Checkpoint Activation by Promoting CDC20 Integration into the MCC; Authors - Qi Li
human	WB,IHC	Carcinogenesis; NUF2 and NEK2 promote malignant progression of gallbladder cancer by remodeling the extracellular matrix; Authors - Ming Gao
human	WB,IP,IHC	Biochem Pharmacol; NUF2 activated by YY1 promotes prostate cancer malignancy via p38/MAPK signaling axis and serves as a therapeutic target; Authors - Chengqi Jin

Avis

The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.

---

FH

Katie (Verified Customer) (05-23-2022)

Works well for western

• Applications: Western Blot
• Primary Antibody Dilution: 1:1000
• Cell Tissue Type: T cells

{{ptg:RelatedPrimaryAntibodies}}